HomepageBIOG-B • STO
add
BioGaia AB
Vorige slotkoers
kr 111,20
Dag-range
kr 109,30 - kr 112,50
Jaar-range
kr 94,75 - kr 136,60
Beurswaarde
11,26 mld. SEK
Gem. volume
121,32K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 303,97 mln. | -4,32% |
Bedrijfskosten | 124,96 mln. | 7,14% |
Netto inkomsten | 36,60 mln. | -63,94% |
Netto winstmarge | 12,04 | -62,32% |
Winst per aandeel | — | — |
EBITDA | 103,72 mln. | -16,66% |
Effectief belastingtarief | 22,09% | — |
Balans
Totale activa
Totale passiva
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,11 mld. | -23,26% |
Totale activa | 1,90 mld. | -17,33% |
Totale passiva | 285,12 mln. | -10,62% |
Totaal aandelenvermogen | 1,62 mld. | — |
Uitstaande aandelen | 101,16 mln. | — |
Koers-boekwaardeverhouding | 6,95 | — |
Rendement op activa | 12,79% | — |
Rendement op kapitaal | 15,24% | — |
Kasstroom
Nettomutatie in liquide middelen
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 36,60 mln. | -63,94% |
Operationele kasstroom | 100,03 mln. | 1,06% |
Kasstroom uit beleggingen | -2,81 mln. | 68,53% |
Kasstroom uit financiering | 14,23 mln. | 939,29% |
Nettomutatie in liquide middelen | 106,86 mln. | 28,81% |
Vrije kasstroom | 74,41 mln. | 104,18% |
Over
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Opgericht
1990
Website
Werknemers
222
